Sign in
NPCE Stock Price, Chart, Stats & News
NeuroPace, Inc.
Save
536.64M
Market cap
–
Current P/E
–
Forward P/E
NPCE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 77.23% |
Operating margin | -16.34% |
Pretax margin | -21.47% |
Net margin | -21.47% |
Effective tax rate | – |
ROA | -20.33% |
ROE | -105.67% |
D/E | 3.72x |
Interest coverage ratio | -2.41x |
NPCE valuation
P/E | – |
P/S | 4.49x |
P/B | 22.92x |
P/CF | -39.63x |
P/FCF | -39.58x |
P/OCF | -39.63x |
PEG | -1.54x |
EV multiple | -28.96x |
About
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely.
Similar securities
Based on sector and market capitalization
Report issue